Corient Private Wealth
TDOC icon

Corient Private Wealth’s Teladoc Health TDOC Stock Holding History

Corient Private Wealth’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Buy
273,003
+197,619
+262% +$1.11M ﹤0.01% 1415
2025
Q4 		$528K Buy
75,384
+64,186
+573% +$503K ﹤0.01% 2274
2025
Q3 		$86.6K Buy
+11,198
New +$87.4K ﹤0.01% 2466
2025
Q2 		– Sell
-13,176
Closed -$105K – 2534
2025
Q1 		$105K Sell
13,176
-12,593
-49% -$127K ﹤0.01% 2168
2024
Q4 		$234K Sell
25,769
-6,175
-19% -$59.6K ﹤0.01% 2029
2024
Q3 		$293K Sell
31,944
-557
-2% -$4.61K ﹤0.01% 2023
2024
Q2 		$318K Buy
+32,501
New +$396K ﹤0.01% 1870
2024
Q1 		– Sell
-9,285
Closed -$200K – 2366
2023
Q4 		$200K Buy
+9,285
New +$171K ﹤0.01% 2079
2023
Q3 		– Sell
-15,889
Closed -$402K – 2232
2023
Q2 		$402K Sell
15,889
-1,536
-9% -$38.7K ﹤0.01% 1556
2023
Q1 		$452K Buy
+17,425
New +$466K ﹤0.01% 1429

Other funds holding TDOC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Private Wealth's TDOC Position: Q1 2026 in Review

Corient Private Wealth increased its Teladoc Health (TDOC) stake by 262% in Q1 2026, buying an estimated $1.11M and bringing the position to 273,003 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1415.

Corient Private Wealth first reported a position in TDOC in Q1 2023 and has held it in 10 quarters since. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Corient Private Wealth held 273,003 shares of Teladoc Health worth $1.49M as of Q1 2026.
  • Corient Private Wealth bought 197,619 Teladoc Health shares in Q1 2026, an estimated $1.11M.
  • Teladoc Health made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1415 holding.
  • Corient Private Wealth first reported a position in Teladoc Health in Q1 2023 and has held it in 10 quarters since.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.